209 related articles for article (PubMed ID: 33497471)
1. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
[TBL] [Abstract][Full Text] [Related]
2. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
[TBL] [Abstract][Full Text] [Related]
4. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
Wang X; Wang H; Wang H; Huang J; Wang X; Jiang Z; Tan L; Jiang D; Hou Y
BMC Cancer; 2021 Feb; 21(1):111. PubMed ID: 33535987
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Obesity on Response to Neoadjuvant Therapy in Locally Advanced Gastric Cancer.
Sakin A; Sahin S; Sakin A; Aldemir MN; Bayram I; Kotan C
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2723-2731. PubMed ID: 32986374
[TBL] [Abstract][Full Text] [Related]
8. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
[TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
[TBL] [Abstract][Full Text] [Related]
10. Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
Yin H; Yao Q; Xie Y; Niu D; Jiang W; Cao H; Feng X; Li Y; Li Y; Zhang X; Shen L; Chen Y
Cancer Med; 2023 Oct; 12(19):19633-19643. PubMed ID: 37749981
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.
Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
Clin Transl Oncol; 2023 Aug; 25(8):2462-2471. PubMed ID: 37093455
[TBL] [Abstract][Full Text] [Related]
12. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
Noble F; Lloyd MA; Turkington R; Griffiths E; O'Donovan M; O'Neill JR; Mercer S; Parsons SL; Fitzgerald RC; Underwood TJ;
Br J Surg; 2017 Dec; 104(13):1816-1828. PubMed ID: 28944954
[TBL] [Abstract][Full Text] [Related]
13. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
[TBL] [Abstract][Full Text] [Related]
14. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
15. Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies.
Hayashi M; Fujita T; Matsushita H
Eur J Surg Oncol; 2021 Aug; 47(8):1996-2003. PubMed ID: 33353828
[TBL] [Abstract][Full Text] [Related]
16. Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer.
Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; Charruf AZ; de Castria TB; Zilberstein B; Ceconello I; Avancini Ferreira Alves V; Ribeiro U; de Mello ES
J Surg Oncol; 2020 Apr; 121(5):795-803. PubMed ID: 31773740
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus.
Takeda FR; Tustumi F; de Almeida Obregon C; Yogolare GG; Navarro YP; Segatelli V; Sallum RAA; Junior UR; Cecconello I
Ann Surg Oncol; 2020 Apr; 27(4):1241-1247. PubMed ID: 31664618
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
20. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]